Phenergan - accessdata.fda.gov
Promethazine is well absorbed from the gastrointestinal tract. Clinical effects are apparent within 20 minutes after oral administration and generally last four to six hours, although they may persist as long
Download Phenergan - accessdata.fda.gov
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
DRUGS USED IN ICU - Weebly
chestgmcpatiala.weebly.comPOLICY OF DRUG USE IN ICU • Patients admitted to the ICU must have a complete drug history documented: a) Premorbid and current medications. b) Previous adverse drug reactions and
MEDICATION MONITORING: Stress Ulcer Prophylaxis …
med.stanford.eduA. Approved indications for stress ulcer prophylaxis4 1. Patients on mechanical ventilation for greater than 48 hours6* 2. Coagulopathy defined as platelet count <50, INR >1.5 or PTT 2x baseline6 * 3.
TIME LOST IS BRAIN LOST. - Stroke Association
www.strokeassociation.orgTARGET: STROKE CAMPAIGN MANUAL 03 Patients who are eligible for treatment with rt-PA within 3 hours of onset of stroke should be treated as recommended in the 2007 Guidelines.
The Diagnosis, Evaluation, and Management of von ...
www.nhlbi.nih.govvon Willebrand Disease FULL REPORT NIH Publication No. 08-5832 December 2007 The Diagnosis, Evaluation, and Management of cx128620_NIH_Cover.qxp:Layout 1 1/8/08 12:25 PM Page 1
Management of IV Fluids and Electrolyte Balance
www.utas.edu.auObjectives Having completed this session you will be able to: • Explain the uses of IV therapy, the role of red and white blood cells, platelets, plasma, and the six major electrolytes in intracellular and